NCT05410821
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +16 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, China
Clinical trial condition
Refractory Thyroid Gland Hurthle Cell Carcinoma
Explore clinical trials studying Refractory Thyroid Gland Hurthle Cell Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Refractory Thyroid Gland Hurthle Cell Carcinoma trial results
NCT01208051
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +17 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center P2C Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States